Flexible partnering models
In all our partnering models, Adaptive provides end-to-end support including hypothesis-driven trial design, extensive data analyses, parallel regulatory support when encessary, compliant data transfer and novel target screening.
Our models range from fee-for-service to diagnostic partnering to data generation for discovery purposes.
Reach out and we can work with you on how our immune medicine platform can accelerate your drug discovery and development efforts.
